DarioHealth stock gained 3.79 percent as Aon backs savings

DarioHealth Announces Independent Aon Analysis that Supports Estimated 2.5%-7.2% In-Year Reduction in Total Healthcare Costs

A study found $5,077 in annual savings per Dario user with type 2 diabetes vs. matched non-users.

DarioHealth (DRIO) director John R. Palumbo receives shares that vest after two years

(DRIO) Price Dynamics and Execution-Aware Positioning

Dario Wins Contract with One of New Jersey's Largest Health Plans Representing 1.5 Million Covered Lives

DarioHealth Secures New Jersey Health Plan Contract Through Amwell Partnership; Dario's Cardiometabolic Suite Launch Set For Q1 2027

Analysts Have Made A Financial Statement On DarioHealth Corp.'s (NASDAQ:DRIO) Second-Quarter Report

DarioHealth (DRIO) Q2 2026 Earnings Call Transcript

DarioHealth Corp (DRIO) (Q2 2026) Earnings Call Highlights: Multi-Condition Platform Drives ...

DarioHealth Corp. Q2 2026 Earnings Call Summary

DarioHealth Q2 Earnings Call Highlights

DarioHealth Corp. (DRIO) Reports Q2 Loss, Lags Revenue Estimates

Dario Launches Integrated GLP-1 Program, Combining Its Digital Chronic Care Platform with Provider-Backed Clinical Care in a Single End-to-End Experience

DarioHealth (DRIO) Moves 12.9% Higher: Will This Strength Last?